This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qi, X. Articles by Dorian, P. Search for Related Content PubMed PubMed Citation Articles by Qi, X. Articles by Dorian, P. Related Collections Arrythmias-basic studies Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2001;104:1544.)
© 2001 American Heart Association, Inc.

Basic Science Reports

Gap Junction Blockers Decrease Defibrillation Thresholds Without Changes in Ventricular Refractoriness in Isolated Rabbit Hearts

Xiangqian Qi, MD, PhD; Pryamvada Varma, MSc; David Newman, MD; Paul Dorian, MD, MSc

From the Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ont, Canada.

Correspondence to Dr Paul Dorian, St Michael’s Hospital, 30 Bond St, Room 7-050Q, Toronto, ON, Canada, M5B 1W8. E-mail dorianp{at}smh.toronto.on.ca

Background— The maintenance and termination of reentry arrhythmias are determined by tissue properties such as refractoriness and conduction velocity. Although the effects of Na⁺ and K⁺ channel block on electrophysiological properties and defibrillation threshold (DFT) have been studied, little is known about the effect of gap junction blockers on defibrillation and tissue electrophysiological properties.

Methods and Results— Triplicate DFTs (volts) were obtained before and 15 minutes after 4 µmol/L 16-doxyl-stearic acid (16-DSA, n=8), 1 mmol/L 1-heptanol (n=12) (both gap junction blockers), 3 µg/mL lidocaine (a sodium channel blocker) (n=8), and respective controls (n=27) in isolated perfused rabbit hearts. DFT decreased after 16-DSA (23±14%, P<0.01) and 1-heptanol (21±16%, P<0.01) but increased after lidocaine (26±28%, P<0.05). Ventricular fibrillation cycle length (VFCL) and QRS duration increased after all 3 agents, by 36±19% and 44±16% (16-DSA), 87±42% and 49±15% (heptanol), and 57±20% and 43±26% (lidocaine), respectively (all P<0.01). Spatially averaged temporal VFCL dispersion decreased significantly after all 3 agents, by 47±42% (16-DSA, P<0.05), 74±19% (1-heptanol, P<0.01), and 82±13% (lidocaine, P<0.01), respectively. Ventricular effective refractory period and monophasic action potential duration at 90% repolarization were unchanged after 16-DSA and 1-heptanol (P=NS) but increased after lidocaine (16±13%, P<0.01, and 6±5%, P=NS, respectively). There were no significant changes in DFT or any other electrophysiological variable in control hearts.

Conclusions— Electrical uncoupling by 16-DSA and 1-heptanol significantly lowers DFT and dispersion of VFCL without altering refractoriness; lidocaine, at doses resulting in similar slowing of conduction, increases DFT.

Key Words: defibrillation • blockers • refractoriness • dispersion

This article has been cited by other articles:

				J.-q. Zhong, G. Laurent, P. P.-S. So, Xudong Hu, J. K. Hennan, and P. Dorian Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 69 - 77. [Abstract] [PDF]

				B. C. Eloff, E. Gilat, X. Wan, and D. S. Rosenbaum Pharmacological Modulation of Cardiac Gap Junctions to Enhance Cardiac Conduction: Evidence Supporting a Novel Target for Antiarrhythmic Therapy Circulation, December 23, 2003; 108(25): 3157 - 3163. [Abstract] [Full Text] [PDF]

				J. J. Sims, K. L. Schoff, J. M. Loeb, and N. A. Wiegert Regional gap junction inhibition increases defibrillation thresholds Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H10 - H16. [Abstract] [Full Text] [PDF]